Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig A Tooman Insider Profile
4 Followers
Craig A Tooman, Chief Financial Officer at Silence Therapeutics, holds 619.68K shares in Ondine Biomedical, Inc. (Ticker: GB:OBI), holds ― shares in Silence Therapeutics (Ticker: GB:SLN). Most recently, Craig A Tooman Bought ― shares of Ondine Biomedical, Inc. on May 04, 2024 for an estimated value of 31.25K.
Craig A Tooman Silence Therapeutics (SLN)Chief Financial Officer
Silence Therapeutics (SLN)
Chief Financial Officer
Ranked #61,164 out of 98,743 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-12.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Craig A Tooman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Craig A Tooman
Craig A Tooman's Trading History
Silence Therapeutics
Apr 19, 2021
―
Informative Buy
200.01K
―
Ondine Biomedical, Inc.
May 04, 2024
Director
Informative Buy
31.25K
£43.38K
List of latest transactions for each holding click on a transaction to see Craig A Tooman's performance on stock
You May Also Like
Craig A Tooman insider profile FAQ
What is the percentage of profitable transactions made by Craig A Tooman?
The percentage of profitable transactions made by Craig A Tooman is 0%.
What is the average return per transaction made by Craig A Tooman?
The average return per transaction made by Craig A Tooman is -12.70%.
What stocks does Craig A Tooman hold?
Craig A Tooman holds: GB:SLN, GB:OBI stocks.
What was Craig A Tooman’s latest transaction?
Craig A Tooman latest transaction was an Informative Buy of 31.25K.
What was Craig A Tooman's most profitable transaction?
Craig A Tooman’s most profitable transaction was an Informative Buy of GB:OBI stock on May 4, 2024. The return on the trade was 0.00%.
What is Craig A Tooman's role in Silence Therapeutics?
Craig A Tooman's role in Silence Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.